top of page
  • Safi Bello

A Ketamine-Based Nasal Spray Is Now an FDA-Approved Depression Treatment

Gizmodo --------- The U.S. Food and Drug Administration has approved the first new kind of depression treatment seen in decades, a nasal spray drug based on the sedative ketamine. The new drug, licensed by Johnson & Johnson’s pharma division, Janssen Pharmaceuticals, isn’t ketamine exactly. It’s derived from esketamine, a chemical sibling of ketamine. It will be sold under the brand name Spravato. To learn more click on the picture below to read the article.

A Ketamine-Based Nasal Spray Is Now an FDA-Approved Depression Treatment - Read More from Gizmodo

2 views
Featured Posts
Recent Posts
Follow Us
  • Instagram
  • Pinterest
  • Tumblr Social Icon
bottom of page